Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Cidara Therapeutics, Inc. (CDTX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cidara Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Cidara Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is CDTX. The reporting company's CIK number is 1610618.
The total value of stock buying since 2005 is $8,965,795.
The total value of stock sales since 2005 is $33,803.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-02||Daruwala Paul (Chief Operating Officer)||Sale||3,295||1.88||6,194|
|2019-10-01||Abdollahian Neil (Chief Business Officer)||Sale||7,284||1.98||14,422|
|2019-09-27||Oien Jessica (General Counsel & Secretary)||Sale||1,001||1.86||1,861|
|2019-09-24||Stein Jeffrey (President & CEO)||Buy||52,500||1.91||100,117|
|2019-09-24||Levine James E. (Chief Financial Officer)||Buy||30,000||1.91||57,240|
|2019-03-08||Abdollahian Neil (Chief Business Officer)||Sale||2,300||2.44||5,612|
|2019-03-07||Daruwala Paul (Chief Operating Officer)||Sale||2,240||2.55||5,714|
|2018-05-23||Stein Jeffrey (President & CEO)||Buy||212,766||4.70||1,000,000|
|2017-11-15||Bb Biotech Ag (10% Owner)||Buy||60,000||7.57||453,960|
|2017-09-12||Stein Jeffrey (President & CEO)||Buy||7,350||6.79||49,906|
|2017-06-07||Sandison Taylor (Chief Medical Officer)||Buy||19,344||5.90||114,129|
|2017-06-06||Sandison Taylor (Chief Medical Officer)||Buy||656||5.90||3,870|
|2017-06-05||Stein Jeffrey (President & CEO)||Buy||15,000||5.95||89,205|
|2017-03-31||Forrest Kevin (Chief Scientific Officer)||Buy||12,500||7.75||96,875|
|2017-03-31||Stein Jeffrey (President & CEO)||Buy||12,900||7.75||99,975|
|2016-05-20||Forrest Kevin (COO & CFO)||Buy||4,356||11.53||50,224|
|2016-05-20||Stein Jeffrey (President & CEO)||Buy||4,310||11.51||49,608|
|2015-11-25||Stein Jeffrey (President & CEO)||Buy||1,300||15.60||20,280|
|2015-11-24||Stein Jeffrey (President & CEO)||Buy||5,400||14.97||80,838|
|2015-11-23||Forrest Kevin (COO & CFO)||Buy||7,087||14.23||100,848|
|2015-04-20||Stein Jeffrey (President & CEO)||Buy||420||16.00||6,720|
|2015-04-20||Franson Timothy R (Director)||Buy||4,000||16.00||64,000|
|2015-04-20||Kjellson Nina S (Director)||Buy||200,000||16.00||3,200,000|
|2015-04-20||Heron Patrick J (Director)||Buy||200,000||16.00||3,200,000|
|2015-04-20||Perez Robert J (Director)||Buy||5,000||16.00||80,000|
|2015-04-20||Burgess Daniel D (Director)||Buy||3,000||16.00||48,000|
Insider trading activities including stock purchases, stock sales, and option exercises of CDTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cidara Therapeutics, Inc. (symbol CDTX, CIK number 1610618) see the Securities and Exchange Commission (SEC) website.